Overview
Background
Apicomplexan tick-borne pathogens that cause disease in companion animals include species of
Babesia
Starcovici, 1893,
Cytauxzoon
Neitz & Thomas, 1948,
Hepatozoon
Miller, 1908 and
Theileria
Bettencourt, Franca & Borges, 1907. The only apicomplexan tick-borne disease of companion animals that is known to occur in Australia is babesiosis, caused by
Babesia canis vogeli
Reichenow, 1937 and
Babesia gibsoni
Patton, 1910
.
However, no molecular investigations have widely investigated members of Apicomplexa Levine, 1980 in Australian ticks that parasitise dogs, cats or horses, until this present investigation.
Results
Ticks (
n
= 711) removed from dogs (
n
= 498), cats (
n
= 139) and horses (
n
= 74) throughout Australia were screened for piroplasms and
Hepatozoon
spp. using conventional PCR and Sanger sequencing. The tick-borne pathogen
B. vogeli
was identified in two
Rhipicephalus sanguineus
Latreille ticks from dogs residing in the Northern Territory and Queensland (QLD).
Theileria orientalis
Yakimov & Sudachenkov, 1931 genotype Ikeda was detected in three
Haemaphysalis longicornis
Neumann ticks from dogs in New South Wales. Unexpectedly, the exotic tick-borne pathogen
Hepatozoon canis
James, 1905 was identified in an
Ixodes holocyclus
Neumann tick from a dog in QLD. Eight novel piroplasm and
Hepatozoon
species were identified and described in native ticks and named as follows:
Babesia lohae
n. sp.,
Babesia mackerrasorum
n. sp.,
Hepatozoon banethi
n. sp.,
Hepatozoon ewingi
n. sp.,
Theileria apogeana
n. sp.,
Theileria palmeri
n. sp.,
Theileria paparinii
n. sp. and
Theileria worthingtonorum
n. sp. Additionally, a novel cf. Sarcocystidae sp. sequence was obtained from
Ixodes tasmani
Neumann but could not be confidently identified at the genus level.
Conclusions
Novel species of parasites in ticks represent an unknown threat to the health of companion animals that are bitten by these native tick species. The vector potential of Australian ticks for the newly discovered apicomplexans needs to be assessed, and further clinical and molecular investigations of these parasites, particularly in blood samples from dogs, cats and horses, is required to determine their potential for pathogenicity.